Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

Abstract Aims This study aimed to assess plasma fibroblast growth factor 23 (FGF23) in patients with heart failure with preserved ejection fraction (HFpEF) and its relation to inflammation, renal function, clinical and imaging characteristics, exercise capacity, and prognosis. Methods and results We...

Full description

Bibliographic Details
Main Authors: Prathap Kanagala, Jayanth R. Arnold, Jamal N. Khan, Anvesha Singh, Gaurav S. Gulsin, Mohamed Eltayeb, Pankaj Gupta, Iain B. Squire, Gerry P. McCann, Leong L. Ng
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:ESC Heart Failure
Subjects:
FGF23
Bone
Exercise capacity
Heart failure with preserved ejection fraction
Inflammation
Prognosis
Online Access:https://doi.org/10.1002/ehf2.13020

Internet

https://doi.org/10.1002/ehf2.13020

Similar Items